Modeling Alzheimer’s disease in mice by selectively lesioning the cholinergic basal forebrain

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Arter, Natalie
dc.contributor.author Wrenn, Craige C.
dc.date.accessioned 2007-06-01T13:27:35Z
dc.date.available 2007-06-01T13:27:35Z
dc.date.issued 2007-06-01T13:27:35Z
dc.identifier.uri http://hdl.handle.net/2092/571
dc.description.abstract One pathological feature of Alzheimer’s disease (AD) is the degeneration of the cholinergic basal forebrain (CBF). The importance of this degeneration in AD is suggested by the observation that the degree of CBF degeneration correlates with the degree of dementia. To model CBF degeneration in mice, we injected the immunotoxin mu-p75-saporin or saline vehicle into the left lateral ventricle. This immunotoxin is designed to selectively kill the neurons of the mouse CBF by targeting the p75 nerve growth factor receptor expressed by CBF neurons. After recovery from immunotoxin injection, the mice were tested using a battery of learning memory tests. Immunotoxin injection did not cause any change in spontaneous motor activity or cued fear conditioning, but it did produce a deficit in contextual fear conditioning and passive avoidance learning. Immunotoxin-injected mice also showed a minor impairment in motor coordination as revealed by testing on the accelerating rotarod. Histochemistry for acetylcholinenesterase showed that immunotoxin injection resulted in a substantial loss of cholinergic fibers in target fields of the CBF such as the hippocampus and neocortex. Immunohistochemistry for calbindin-D28K showed that there was no loss of cerebellar Purkinje cells, which, like the CBF, express p75. Future work will further determine the selectivity of mu-p75-saporin by performing immunohistochemistry for p75 and parvalbumin in the CBF of immunotoxin-injected mice. In summary, the present data support the use of mu-p75-saporin to model key pathological and behavioral features of AD in the laboratory mouse. The utility of this model will be to serve as a screening tool for new drug therapies, especially when used in combination with transgenic mouse models of other pathological features of AD. en
dc.format.extent 2274564 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US
dc.relation.ispartofseries DUCURS 2006;27
dc.subject Alzheimer's disease en
dc.subject Cholinergic mechanisms en
dc.subject Cholinergic basal forebrain en
dc.subject Memory en
dc.subject Learning en
dc.subject Neurobiology en
dc.title Modeling Alzheimer’s disease in mice by selectively lesioning the cholinergic basal forebrain en
dc.type Presentation en


Files in this item

This item appears in the following Collection(s)

  • DUCURS [196]
    Poster sessions and presentation from the Drake University Conference on Undergraduate Research in the Sciences held each April at Olmsted Center on the Drake campus.

Show simple item record

Search DSpace


Advanced Search

Browse

My Account